| scholarly article | Q13442814 |
| P356 | DOI | 10.1038/S41433-019-0731-5 |
| P698 | PubMed publication ID | 31844169 |
| P2093 | author name string | Marian Ludgate | |
| P2860 | cites work | Graves' ophthalmopathy | Q28274196 |
| Bidirectional TSH and IGF-1 receptor cross talk mediates stimulation of hyaluronan secretion by Graves' disease immunoglobins | Q35096870 | ||
| Independent adipogenic and contractile properties of fibroblasts in Graves' orbitopathy: an in vitro model for the evaluation of treatments. | Q35154018 | ||
| Development of a disease specific quality of life questionnaire for patients with Graves' ophthalmopathy: the GO-QOL. | Q35305938 | ||
| Thy-1 Expression in Human Fibroblast Subsets Defines Myofibroblastic or Lipofibroblastic Phenotypes | Q35792099 | ||
| The thyroid, the eyes and the gut: a possible connection | Q36243615 | ||
| Effector T-cell subsets in systemic lupus erythematosus: update focusing on Th17 cells | Q36373858 | ||
| Thyrotropin receptor activation increases hyaluronan production in preadipocyte fibroblasts: contributory role in hyaluronan accumulation in thyroid dysfunction. | Q38351966 | ||
| Graves' orbitopathy as a rare disease in Europe: a European Group on Graves' Orbitopathy (EUGOGO) position statement. | Q38692635 | ||
| Thy-1 interaction with Fas in lipid rafts regulates fibroblast apoptosis and lung injury resolution | Q38717775 | ||
| IL-17A Exacerbates Fibrosis by Promoting the Proinflammatory and Profibrotic Function of Orbital Fibroblasts in TAO. | Q38862604 | ||
| The microbiota and autoimmunity: Their role in thyroid autoimmune diseases. | Q39423923 | ||
| Orbital Fibroblasts From Graves' Orbitopathy Patients Share Functional and Immunophenotypic Properties With Mesenchymal Stem/Stromal Cells | Q40442085 | ||
| The thyrotropin receptor in thyroid diseases. | Q41653132 | ||
| Biological effects of thyrotropin receptor activation on human orbital preadipocytes | Q42504520 | ||
| Adipose thyrotrophin receptor expression is elevated in Graves' and thyroid eye diseases ex vivo and indicates adipogenesis in progress in vivo | Q44468299 | ||
| Reevaluating thyrotropin receptor-induced mouse models of graves' disease and ophthalmopathy. | Q45149782 | ||
| Comparative Assessment of Female Mouse Model of Graves' Orbitopathy Under Different Environments, Accompanied by Proinflammatory Cytokine and T-Cell Responses to Thyrotropin Hormone Receptor Antigen. | Q50931731 | ||
| Association of T and B Cells Infiltrating Orbital Tissues With Clinical Features of Graves Orbitopathy. | Q52715564 | ||
| Gut microbiota in experimental murine model of Graves' orbitopathy established in different environments may modulate clinical presentation of disease. | Q55379805 | ||
| Thy-1 in Integrin Mediated Mechanotransduction | Q63976745 | ||
| Role of the Gut-Liver Axis in Liver Inflammation, Fibrosis, and Cancer: A Special Focus on the Gut Microbiota Relationship | Q64077761 | ||
| Thy-1 as an Integrator of Diverse Extracellular Signals | Q64104628 | ||
| Studies on the occurrence of ophthalmopathy in Graves' disease | Q69606497 | ||
| Demonstration of immunoglobulin G, A, and E autoantibodies to the human thyrotropin receptor using flow cytometry | Q77878112 | ||
| Thyrotropin receptor autoantibodies are independent risk factors for Graves' ophthalmopathy and help to predict severity and outcome of the disease | Q79885195 | ||
| Smoking and the intestinal microbiome | Q88295563 | ||
| Serum antibodies against the insulin-like growth factor-1 receptor (IGF-1R) in Graves' disease and Graves' orbitopathy | Q91073029 | ||
| Insulin-like Growth Factor-I Receptor and Thyroid-Associated Ophthalmopathy | Q91445468 | ||
| P433 | issue | 2 | |
| P921 | main subject | eye disease | Q3041498 |
| P304 | page(s) | 279-284 | |
| P577 | publication date | 2019-12-16 | |
| P1433 | published in | Eye | Q10278937 |
| P1476 | title | Fibrosis in dysthyroid eye disease | |
| P478 | volume | 34 |
Search more.